222 related articles for article (PubMed ID: 11773638)
1. Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo.
Segev DL; Hoshiya Y; Hoshiya M; Tran TT; Carey JL; Stephen AE; MacLaughlin DT; Donahoe PK; Maheswaran S
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):239-44. PubMed ID: 11773638
[TBL] [Abstract][Full Text] [Related]
2. Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo.
Segev DL; Hoshiya Y; Stephen AE; Hoshiya M; Tran TT; MacLaughlin DT; Donahoe PK; Maheswaran S
J Biol Chem; 2001 Jul; 276(29):26799-806. PubMed ID: 11356848
[TBL] [Abstract][Full Text] [Related]
3. Mullerian inhibiting substance regulates androgen-induced gene expression and growth in prostate cancer cells through a nuclear factor-kappaB-dependent Smad-independent mechanism.
Tran TT; Segev DL; Gupta V; Kawakubo H; Yeo G; Donahoe PK; Maheswaran S
Mol Endocrinol; 2006 Oct; 20(10):2382-91. PubMed ID: 16740653
[TBL] [Abstract][Full Text] [Related]
4. Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway.
Segev DL; Ha TU; Tran TT; Kenneally M; Harkin P; Jung M; MacLaughlin DT; Donahoe PK; Maheswaran S
J Biol Chem; 2000 Sep; 275(37):28371-9. PubMed ID: 10874041
[TBL] [Abstract][Full Text] [Related]
5. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
6. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
Gupta V; Yeo G; Kawakubo H; Rangnekar V; Ramaswamy P; Hayashida T; MacLaughlin DT; Donahoe PK; Maheswaran S
Cancer Res; 2007 Mar; 67(6):2747-56. PubMed ID: 17363596
[TBL] [Abstract][Full Text] [Related]
7. Mullerian Inhibiting Substance induces NFkB signaling in breast and prostate cancer cells.
Hoshiya Y; Gupta V; Segev DL; Hoshiya M; Carey JL; Sasur LM; Tran TT; Ha TU; Maheswaran S
Mol Cell Endocrinol; 2003 Dec; 211(1-2):43-9. PubMed ID: 14656475
[TBL] [Abstract][Full Text] [Related]
8. Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung.
Catlin EA; Tonnu VC; Ebb RG; Pacheco BA; Manganaro TF; Ezzell RM; Donahoe PK; Teixeira J
Endocrinology; 1997 Feb; 138(2):790-6. PubMed ID: 9003016
[TBL] [Abstract][Full Text] [Related]
9. Regulation of gonadotropin gene expression by Mullerian inhibiting substance.
Bédécarrats GY; O'Neill FH; Norwitz ER; Kaiser UB; Teixeira J
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9348-53. PubMed ID: 12878721
[TBL] [Abstract][Full Text] [Related]
10. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
[TBL] [Abstract][Full Text] [Related]
11. The in vivo roles of müllerian-inhibiting substance.
Behringer RR
Curr Top Dev Biol; 1994; 29():171-87. PubMed ID: 7828438
[TBL] [Abstract][Full Text] [Related]
12. Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.
Ingraham HA; Hirokawa Y; Roberts LM; Mellon SH; McGee E; Nachtigal MW; Visser JA
Recent Prog Horm Res; 2000; 55():53-67; discussion 67-8. PubMed ID: 11036933
[TBL] [Abstract][Full Text] [Related]
13. Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.
Teixeira J; Fynn-Thompson E; Payne AH; Donahoe PK
Endocrinology; 1999 Oct; 140(10):4732-8. PubMed ID: 10499532
[TBL] [Abstract][Full Text] [Related]
14. The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling.
Visser JA; Olaso R; Verhoef-Post M; Kramer P; Themmen AP; Ingraham HA
Mol Endocrinol; 2001 Jun; 15(6):936-45. PubMed ID: 11376112
[TBL] [Abstract][Full Text] [Related]
15. The müllerian inhibitor and mammalian sexual development.
Behringer RR
Philos Trans R Soc Lond B Biol Sci; 1995 Nov; 350(1333):285-8; discussion 289. PubMed ID: 8570693
[TBL] [Abstract][Full Text] [Related]
16. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
Zhan Y; Fujino A; MacLaughlin DT; Manganaro TF; Szotek PP; Arango NA; Teixeira J; Donahoe PK
Development; 2006 Jun; 133(12):2359-69. PubMed ID: 16687449
[TBL] [Abstract][Full Text] [Related]
17. Expression of MIS in the testis is downregulated by tumor necrosis factor alpha through the negative regulation of SF-1 transactivation by NF-kappa B.
Hong CY; Park JH; Seo KH; Kim JM; Im SY; Lee JW; Choi HS; Lee K
Mol Cell Biol; 2003 Sep; 23(17):6000-12. PubMed ID: 12917325
[TBL] [Abstract][Full Text] [Related]
18. Expression of the NF-kappa B target gene X-ray-inducible immediate early response factor-1 short enhances TNF-alpha-induced hepatocyte apoptosis by inhibiting Akt activation.
Osawa Y; Nagaki M; Banno Y; Brenner DA; Nozawa Y; Moriwaki H; Nakashima S
J Immunol; 2003 Apr; 170(8):4053-60. PubMed ID: 12682234
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.
Kurian MS; de la Cuesta RS; Waneck GL; MacLaughlin DT; Manganaro TF; Donahoe PK
Clin Cancer Res; 1995 Mar; 1(3):343-9. PubMed ID: 9815990
[TBL] [Abstract][Full Text] [Related]
20. Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107.
Barbie TU; Barbie DA; MacLaughlin DT; Maheswaran S; Donahoe PK
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15601-6. PubMed ID: 14671316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
